Related Experiment Video
Updated: May 27, 2026

A Novel High-Throughput Ex Vivo Ovine Skin Wound Model for Testing Emerging Antibiotics
Published on: September 16, 2022
Acute bacterial skin and skin structure infections: current perspective
1Medical College, Vadodara, Gujarat, India.
Abstract:
A skin and skin structure infection is a bacterial infection of skin and associated tissues. It may be complicated skin and skin structure infection or uncomplicated skin and skin structure infection. Recently, the Food and Drug Administration has called them acute bacterial skin and skin structure infections (ABSSSI). ABSSSI are common and encompass a variety of disease presentations and severity. Increased antimicrobial resistance among both Gram-positive and Gram-negative bacteria with methicillin-resistant Staphylococcus aureus is the main problem in treatment. So, development of newer agents to fight against resistant microbes is the need of the hour. Ceftaroline, a newer cephalosporin, is one promising agent.
Insights
Acute bacterial skin and skin structure infections (ABSSSI) are common and challenging due to rising antimicrobial resistance. Ceftaroline shows promise as a new agent to combat these resistant bacterial infections.
Area of Science:
- Infectious Diseases
- Microbiology
- Pharmacology
Background:
- Acute bacterial skin and skin structure infections (ABSSSI) represent a significant clinical challenge.
- Treatment is complicated by increasing antimicrobial resistance, particularly from Gram-positive bacteria like methicillin-resistant Staphylococcus aureus (MRSA).
Purpose of the Study:
- To highlight the growing problem of antimicrobial resistance in ABSSSI.
- To introduce ceftaroline as a potential therapeutic agent against resistant bacterial pathogens.
Main Methods:
- Literature review on ABSSSI epidemiology and resistance patterns.
- Review of pharmacological data for ceftaroline efficacy.
Main Results:
- Antimicrobial resistance is a primary concern in managing ABSSSI.
- Ceftaroline demonstrates potential as a novel therapeutic option.
Conclusions:
- There is an urgent need for new antimicrobial agents to treat ABSSSI.
- Ceftaroline is a promising cephalosporin for addressing resistant bacterial infections.
Related Concept Videos
Staphylococcal Skin Infections
Skin Diseases and Disorders
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
The Skin Microbiota
Acne Infection
Urinary Tract Infection II: Pathophysiology
Clinical Significance of Antibiotic Resistance
